Impact of Vendor Systems on Ambulatory Medication Safety (BWHCERT5E)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00773500
First received: October 3, 2008
Last updated: February 27, 2012
Last verified: February 2012

October 3, 2008
February 27, 2012
September 2008
July 2011   (final data collection date for primary outcome measure)
prescribing error [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
medication errors [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
Complete list of historical versions of study NCT00773500 on ClinicalTrials.gov Archive Site
  • near misses [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
  • preventable adverse drug events [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Impact of Vendor Systems on Ambulatory Medication Safety
Impact of Vendor Systems on Ambulatory Medication Safety

Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.

We will compare the effects of different vendor-based electronic prescribing systems on ambulatory medication safety in various settings, including rural and underserved areas and determine the effects of electronic prescribing systems on ambulatory medication safety over time.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Our study will take place in 2 NYS communities. We will select 2 communities in order to assemble a study population with the following characteristics: use of at least 2 different vendor-based systems, different implementation times (with some communities being early adopters and others experienced users), and inclusion of urban underserved and federally defined rural areas.

We will select the following 2 communities/organizations: the community health centers implementing electronic prescribing with the New York City Department of Health (NYC DOH) and the Taconic Health Information Network and Community (THINC) in the Hudson Valley of New York. Both communities have expressed their interest in participating in this study.

Medication Errors
Other: Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
  • 1
    Providers adopting electronic prescribing in New York City, New York
    Intervention: Other: Electronic prescribing
  • 2
    Providers adopting electronic prescribing in the Taconic region of New York
    Intervention: Other: Electronic prescribing
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
October 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • >=0.75 FTE providers

Exclusion Criteria:

  • <0.75 FTE providers
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00773500
U18HS0169705E
No
Weill Medical College of Cornell University
Weill Medical College of Cornell University
Agency for Healthcare Research and Quality (AHRQ)
Principal Investigator: Rainu Kaushal, MD, MPH Weill Medical College of Cornell University
Weill Medical College of Cornell University
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP